National Center for Orthopedics and Sports Rehabilitation Launches Joint Observation Research Project in Boao with Johnson & Johnson

ShanghaiNovember 19, 2019 /PRNewswire/ -- Johnson & Johnson Medical and the Hainan Boao Lecheng International Medical Tourism Pilot Zone officially launched the Joint Observation Study Project of the National Clinical Research Center for Orthopedics and Sports Rehabilitation. The project is led and guided by Professor Tang Peifu, Director of the Department of Orthopedics at the First Medical Center of the Chinese PLA General Hospital, aiming to establish ChinaLeadingThe joint clinical research team conducts real-world clinical observations of joint surgery, accelerates the introduction of new foreign technologies and the implementation of novel surgical techniques, and promotes the development of minimally invasive joint surgery in the Boao Pilot Zone.

Liu Zhefeng, Deputy Director of the Administration Bureau of Boao Lecheng International Medical Tourism Pilot ZoneExpressed strong appreciation for the collaborative project: “Under the policy guidance and impetus of the Boao Lecheng International Medical Tourism Pilot Zone, Hainan Boao encourages and welcomes more companies with new technologies, new equipment, and new products, such as Johnson & Johnson, to enter the Pilot Zone, thereby accelerating the introduction into China of advanced medical technologies that are urgently needed for clinical use and have already been approved for marketing overseas. As this golden brand in healthcare gradually takes shape, domesticWell-knownMedical experts, globally advanced medical devices, and cutting-edge high-end technologies have converged, creating a powerful force that will undoubtedly drive the deep integration and development of the healthcare industry.”

There are up to 150 million patients with osteoarticular diseases in China. Artificial joint replacement surgery is the most effective definitive treatment for joint diseases, and the outcomes of orthopedic surgeries have a profound impact on patients' mobility and quality of life.Tang Peifu, Director of the Department of Orthopedics, First Medical Center of the Chinese PLA General HospitalIt stated: “The National Clinical Research Center for Orthopedics and Sports Rehabilitation is a national-level clinical medical research center jointly approved by four ministries and commissions, including the Ministry of Science and Technology; the Boao Lecheng International Medical Tourism Pilot Zone is a ‘highland’ for academic innovation at the national level; and Johnson & Johnson is a global pioneer in the healthcare industry. The collaboration among these three parties aims to fully leverage their respective strengths to comprehensively address challenges in China’s orthopedic and sports medicine clinical research, such as clinical data collection and new product registration, thereby providing robust support for the Healthy China initiative!””

Zhang Minghai, President of Boao Super TCM HospitalIt was also emphasized that, as the primary clinical observational research base for the cooperative project, Boao Super Hospital of Traditional Chinese Medicine will establish an integrated platform for cultural heritage and clinical diagnosis and treatment, combining four key functions: heritage preservation, medical care, promotion, and incubation. By concentrating superior resources, the hospital aims to enable more advanced technologies and better new products to benefit Chinese patients suffering from bone and joint diseases.

Chen Min, General Manager of the Orthopedics Division, Johnson & Johnson Medicalstated: “Innovation in the health sector primarily encompasses technological innovation, business format innovation, and model innovation. In this minimally invasive joint collaboration project, Johnson & Johnson can provide comprehensive support through high-end products,”Leadingleveraging expert resources and a robust training system to assist the National Clinical Research Center for Orthopedics and Sports Rehabilitation in completing real-world clinical observational studies on minimally invasive joint procedures, establishing the first Joint Center in the Boao Leverage Zone, and contributing to the development of orthopedics in the Boao Leverage Zone to the best of its ability.”

This project also marks the third collaboration between Johnson & Johnson MedTech and the Boao Lecheng Pilot Zone within the year. Earlier this year, the first fully visualized cardiac surgery with dual magnetic-electric positioning under Johnson & Johnson MedTech was successfully performed at Boao Super Hospital. Shortly thereafter, the “Johnson & Johnson Advanced Technologies Hainan Boao Education Center” was established at the Super Hospital. As the first incubation base and education center for top-tier medical talent in the Hainan Boao Lecheng Pilot Zone, it introduces cutting-edge international medical technologies and products to China, providing patients at the Super Hospital with treatment outcomes and experiences on par with global standards.

Since entering the Chinese market in 1994, Johnson & Johnson MedTech has consistently adhered to the values enshrined in Johnson & Johnson’s Our Credo, dedicated to continuously introducing advanced medical technologies and devices to China. The company is committed to providing innovative, high-quality products and services to patients and consumers in China. As the initiative deepens, Johnson & Johnson will also introduce cutting-edge innovations such as the Attune Revision System, representing the next generation of global knee revision prostheses, and the Johnson & Johnson knee robotics system, thereby comprehensively safeguarding the future of orthopedic surgery.